Correction to “Realizing precision medicine in chronic lymphocytic leukemia: Remaining challenges and potential opportunities”
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsChronic Lymphocytic Leukemia Research · Multiple Myeloma Research and Treatments · Chronic Myeloid Leukemia Treatments
Stamatopoulos K, Pavlova S, Al‐Sawaf O, et al. Realizing precision medicine in chronic lymphocytic leukemia: remaining challenges and potential opportunities. HemaSphere. 2024;8(7):e113. doi:10.1002/hem3.113
A funder was incorrectly acknowledged in the original article. In the funding section, the sentence ‘…by the Italian Ministry of Health, grant PNRR‐MAD‐2022‐12376441 (Paolo Ghia) “Leukemic cell and microenvironment interactions as the culprit of chronicity in CLL” and grant PNRR‐MAD‐2022‐12375673 (Gianluca Gaidano) (Next Generation EU, M6/C2_CALL2022)…’ should have read ‘…by the European Union—Next Generation EU—NRRP M6C2—Investment 2.1 Enhancement and strengthening of biomedical research in the NHS—grant PNRR‐MAD‐2022‐12376441 (Paolo Ghia) cup master C43C22001280007 and grant PNRR‐MAD‐2022‐12375673 (Gianluca Gaidano) cup master J53C22004080001….’
The original article has been updated. We apologize for this error.